These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 18714179

  • 1. Downregulation of SS18-SSX1 expression by small interfering RNA inhibits growth and induces apoptosis in human synovial sarcoma cell line HS-SY-II in vitro.
    Peng C, Guo W, Yang Y, Zhao H.
    Eur J Cancer Prev; 2008 Oct; 17(5):392-8. PubMed ID: 18714179
    [Abstract] [Full Text] [Related]

  • 2. Differential roles of SS18-SSX fusion gene and insulin-like growth factor-1 receptor in synovial sarcoma cell growth.
    Törnkvist M, Natalishvili N, Xie Y, Girnita A, D'Arcy P, Brodin B, Axelson M, Girnita L.
    Biochem Biophys Res Commun; 2008 Apr 11; 368(3):793-800. PubMed ID: 18267106
    [Abstract] [Full Text] [Related]

  • 3. Histone deacetylase inhibitors reverse SS18-SSX-mediated polycomb silencing of the tumor suppressor early growth response 1 in synovial sarcoma.
    Lubieniecka JM, de Bruijn DR, Su L, van Dijk AH, Subramanian S, van de Rijn M, Poulin N, van Kessel AG, Nielsen TO.
    Cancer Res; 2008 Jun 01; 68(11):4303-10. PubMed ID: 18519690
    [Abstract] [Full Text] [Related]

  • 4. Downregulation of SS18-SSX1 expression in synovial sarcoma by small interfering RNA enhances the focal adhesion pathway and inhibits anchorage-independent growth in vitro and tumor growth in vivo.
    Takenaka S, Naka N, Araki N, Hashimoto N, Ueda T, Yoshioka K, Yoshikawa H, Itoh K.
    Int J Oncol; 2010 Apr 01; 36(4):823-31. PubMed ID: 20198325
    [Abstract] [Full Text] [Related]

  • 5. Loss of SS18-SSX1 inhibits viability and induces apoptosis in synovial sarcoma.
    Carmody Soni EE, Schlottman S, Erkizan HV, Uren A, Toretsky JA.
    Clin Orthop Relat Res; 2014 Mar 01; 472(3):874-82. PubMed ID: 23716114
    [Abstract] [Full Text] [Related]

  • 6. The synovial-sarcoma-associated SS18-SSX2 fusion protein induces epigenetic gene (de)regulation.
    de Bruijn DR, Allander SV, van Dijk AH, Willemse MP, Thijssen J, van Groningen JJ, Meltzer PS, van Kessel AG.
    Cancer Res; 2006 Oct 01; 66(19):9474-82. PubMed ID: 17018603
    [Abstract] [Full Text] [Related]

  • 7. A novel fusion gene, SS18L1/SSX1, in synovial sarcoma.
    Storlazzi CT, Mertens F, Mandahl N, Gisselsson D, Isaksson M, Gustafson P, Domanski HA, Panagopoulos I.
    Genes Chromosomes Cancer; 2003 Jun 01; 37(2):195-200. PubMed ID: 12696068
    [Abstract] [Full Text] [Related]

  • 8. SYT-SSX is critical for cyclin D1 expression in synovial sarcoma cells: a gain of function of the t(X;18)(p11.2;q11.2) translocation.
    Xie Y, Skytting B, Nilsson G, Gasbarri A, Haslam K, Bartolazzi A, Brodin B, Mandahl N, Larsson O.
    Cancer Res; 2002 Jul 01; 62(13):3861-7. PubMed ID: 12097301
    [Abstract] [Full Text] [Related]

  • 9. Identification of SHCBP1 as a novel downstream target gene of SS18-SSX1 and its functional analysis in progression of synovial sarcoma.
    Peng C, Zhao H, Chen W, Song Y, Wang X, Li J, Qiao Y, Wu D, Ma S, Wang X, Gao C.
    Oncotarget; 2016 Oct 11; 7(41):66822-66834. PubMed ID: 27572315
    [Abstract] [Full Text] [Related]

  • 10. The SYT-SSX1 fusion type of synovial sarcoma is associated with increased expression of cyclin A and D1. A link between t(X;18)(p11.2; q11.2) and the cell cycle machinery.
    Xie Y, Skytting B, Nilsson G, Grimer RJ, Mangham CD, Fisher C, Shipley J, Bjerkehagen B, Myklebost O, Larsson O.
    Oncogene; 2002 Aug 22; 21(37):5791-6. PubMed ID: 12173050
    [Abstract] [Full Text] [Related]

  • 11. IGF2 is critical for tumorigenesis by synovial sarcoma oncoprotein SYT-SSX1.
    Sun Y, Gao D, Liu Y, Huang J, Lessnick S, Tanaka S.
    Oncogene; 2006 Feb 16; 25(7):1042-52. PubMed ID: 16247461
    [Abstract] [Full Text] [Related]

  • 12. Small interference RNA targeting heat-shock protein 27 inhibits the growth of prostatic cell lines and induces apoptosis via caspase-3 activation in vitro.
    Rocchi P, Jugpal P, So A, Sinneman S, Ettinger S, Fazli L, Nelson C, Gleave M.
    BJU Int; 2006 Nov 16; 98(5):1082-9. PubMed ID: 16879439
    [Abstract] [Full Text] [Related]

  • 13. Molecular detection of SS18-SSX fusion gene transcripts by cRNA in situ hybridization in synovial sarcoma using formalin-fixed, paraffin-embedded tumor tissue specimens.
    Kanemitsu S, Hisaoka M, Shimajiri S, Matsuyama A, Hashimoto H.
    Diagn Mol Pathol; 2007 Mar 16; 16(1):9-17. PubMed ID: 17471153
    [Abstract] [Full Text] [Related]

  • 14. Establishment of a new human synovial sarcoma cell line, FU-SY-1, that expresses c-Met receptor and its ligand hepatocyte growth factor.
    Nishio J, Iwasaki H, Ishiguro M, Ohjimi Y, Fujita C, Isayama T, Naito M, Oda Y, Kaneko Y, Kikuchi M.
    Int J Oncol; 2002 Jul 16; 21(1):17-23. PubMed ID: 12063544
    [Abstract] [Full Text] [Related]

  • 15. Induction of p21(WAF1/CIP1) by human synovial sarcoma-associated chimeric oncoprotein SYT-SSX1.
    Tsuda M, Watanabe T, Seki T, Kimura T, Sawa H, Minami A, Akagi T, Isobe K, Nagashima K, Tanaka S.
    Oncogene; 2005 Dec 01; 24(54):7984-90. PubMed ID: 16103879
    [Abstract] [Full Text] [Related]

  • 16. SS18-SSX fusion protein-induced Wnt/β-catenin signaling is a therapeutic target in synovial sarcoma.
    Trautmann M, Sievers E, Aretz S, Kindler D, Michels S, Friedrichs N, Renner M, Kirfel J, Steiner S, Huss S, Koch A, Penzel R, Larsson O, Kawai A, Tanaka S, Sonobe H, Waha A, Schirmacher P, Mechtersheimer G, Wardelmann E, Büttner R, Hartmann W.
    Oncogene; 2014 Oct 16; 33(42):5006-16. PubMed ID: 24166495
    [Abstract] [Full Text] [Related]

  • 17. The role of TLE1 in synovial sarcoma.
    Seo SW, Lee H, Lee HI, Kim HS.
    J Orthop Res; 2011 Jul 16; 29(7):1131-6. PubMed ID: 21319215
    [Abstract] [Full Text] [Related]

  • 18. Synovial sarcoma is a stem cell malignancy.
    Naka N, Takenaka S, Araki N, Miwa T, Hashimoto N, Yoshioka K, Joyama S, Hamada K, Tsukamoto Y, Tomita Y, Ueda T, Yoshikawa H, Itoh K.
    Stem Cells; 2010 Jul 16; 28(7):1119-31. PubMed ID: 20518020
    [Abstract] [Full Text] [Related]

  • 19. G3139 antisense oligonucleotide directed against antiapoptotic Bcl-2 enhances doxorubicin cytotoxicity in the FU-SY-1 synovial sarcoma cell line.
    Joyner DE, Albritton KH, Bastar JD, Randall RL.
    J Orthop Res; 2006 Mar 16; 24(3):474-80. PubMed ID: 16450387
    [Abstract] [Full Text] [Related]

  • 20. Targeting of cell survival genes using small interfering RNAs (siRNAs) enhances radiosensitivity of Grade II chondrosarcoma cells.
    Kim DW, Seo SW, Cho SK, Chang SS, Lee HW, Lee SE, Block JA, Hei TK, Lee FY.
    J Orthop Res; 2007 Jun 16; 25(6):820-8. PubMed ID: 17343283
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.